Bortezomib Copay Assistance

援助如何运作

通过无与伦比的全方位服务便利性，简化患者的专业药房体验

1. 检查您的保险范围/福利验证
我们的专业出纳员团队会找到最佳的保险途径，以最大程度地减少自付费用。
2. 将处方转移到 AmeriPharma®
我们与您之前的药房或处方人员合作来处理您的处方，使过渡变得快速而简单。
3. 事先授权
我们的专家团队将在 24 至 72 小时内获得您保险公司的批准。
4. 共付额援助和经济援助
我们确保患者获得经济援助，并降低共付额、自付费用和高额免赔额。迄今为止，AmeriPharma® 专科护理已为患者争取到 1TP4.4755 亿美元的经济援助。
5.护理协调
AmeriPharma® 在安排和协调我们的专业护士为您进行家庭输液时，会将您的日程安排和家庭环境放在首位。
6. 交付协调
药品始终严格遵守运输的具体要求。次日或隔夜冷链配送将根据您的时间安排进行协调。

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/pharmacist.jpg

What Is Bortezomib?

Bortezomib (brand name: Velcade) is an anti-cancer drug used to treat cancer conditions such as multiple myeloma and mantle cell lymphoma. It is usually administered to people whose conditions have not improved after different treatment therapies.

The drug works by killing cancer cells. However, it is important to keep in mind that the drug does not cure any of these conditions. Instead, it only treats these conditions and helps put them into remission.

https://ameripharmaspecialty.com/wp-content/uploads/2024/02/block_image_1.jpg

它是如何工作的？

Bortezomib belongs to a class of cancer drugs known as proteasome inhibitors. It restricts and prevents the growth of proteasomes in human cells.

Proteasomes exist in the cells, and their major function is to break down the protein the cell does not need. Thus, when you use proteasome inhibitors, it prevents the proteasomes from performing their function, and protein builds up in the cells, causing the cells to die.

In patients with multiple myeloma and mantle cell lymphoma, bortezomib targets the cancer cells because cancer cells are more sensitive to the effects of bortezomib. It prevents the proteasomes in these cells from performing their functions, leading to the death of the cancer cells.

共付额和经济援助

AmeriPharma™ 专业药房减轻患者及其家人的经济负担

先进的软件可以定位资金来源，为您匹配高额的基金会项目
我们的一位共付额援助专家将协助您完成申请流程
自动更新信息将发送给您和您的医生，告知您资金状况

https://ameripharmaspecialty.com/wp-content/uploads/2024/05/doctor-patient.jpg

药品管理局

Bortezomib is usually administered under the skin (subcutaneously) or into the bloodstream (intravenously). Subcutaneously, you can get the injection in your thigh or abdomen. Regardless of where you are getting the injection, you should change the injection site every time you get the injection to reduce pain and injury to the skin.

The drug is administered twice weekly for two weeks. After two weeks, there is a 13-day rest period, completing the three weeks of the cycle. You will have this treatment cycle for a maximum of 8 cycles.

If the levels of Serum M (a type of protein made by myeloma cells) in your body have been reduced, the treatment is working, and you will complete two more treatment cycles. You will continue eight more treatment cycles if the levels have not reduced significantly. However, cycles may vary for patients depending on the severity of their condition. Hence, your doctor will determine what is most suitable for you.

Bortezomib Side Effects

Some side effects associated with using bortezomib include:

弱点
便秘
恶心
头晕
呕吐
食欲不振
疼痛
头痛

In extreme cases, nausea, diarrhea, and vomiting may get severe. You should contact your pharmacist or doctor whenever you experience severe side effects.

Another peculiar side effect you may experience after using the drug is tumor lysis syndrome. This side effect occurs due to the rapid destruction of cancer cells. To reduce the risk of this side effect, it’s advisable you drink lots of water and take additional recommended medications as directed.

Anemia is another side effect that you might experience with bortezomib. This is because the medication might decrease the number of red blood cells in the body. This side effect results in the body feeling tired and weak.

Finally, a rash is another side effect that comes with the use of this medication. However, the rash should not be serious and should go away quickly. Developing severe allergic reactions to bortezomib is rare and was not reported in the 临床研究 carried out to test the efficacy of the medication. Thus, if you experience any severe allergic reaction, you should immediately contact your doctor or pharmacist.